Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting Aug 26, 2026
Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results Mar 30, 2026
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure Jan 20, 2026
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting Sep 15, 2025
